Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
48.50    -1.00 (-2.02%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £44.46m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Q1 Trading Update

24 Sep 2025 07:01

RNS Number : 4899A
Time Finance PLC
24 September 2025
Β 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

Β 

24 September 2025

Time Finance plc

("Time Finance", the "Group" or the "Company")

Β 

Q1 Trading Update

Β 

Record Quarterly Revenues, Record Net Tangible Assets and Record Lending Book

Β 

Time Finance plc, the AIM listed independent specialist finance provider is pleased to provide the following update on the Group's trading performance for the first quarter of the current financial year covering the three months to 31 August 2025. The results reflect the continued strong demand for the Group's multi-product funding offering which has resulted in further growth across all key financial metrics. The lending book has now enjoyed seventeen consecutive quarters of growth, while the Group's continued lending discipline has delivered unchanged levels of arrears and write-offs.

Β 

Unaudited Q1 2025/26 financial highlights:

Β· Own-Book Lending Origination up 30% to Β£28.5m (Q1 2024/25: Β£22.0m)

Β· Revenue up 3% to Β£9.4m (Q1 2024/25: Β£9.1m)

Β· Profit before Tax up 11% to Β£2.1m (Q1 2024/25: Β£1.9m)

Β· Profit Before Tax margin up 100 bps to 22% (Q1 2024/25: 21%)

Β· Net Tangible Assets up 14% to Β£45.6m at 31 August 2025 (31 August 2024: Β£40.1m)

Β· Gross Lending Book up 8% to Β£221.1m at 31 August 2025 (31 August 2024: Β£205.3m)

Β· Net Arrears unchanged at 5% of the gross lending book at 31 August 2025 (31 August 2024: 5%)

Β· Net Bad Debt Write-Offs unchanged at 1% of the average gross lending book at 31 August 2025 (31 August 2024: 1%)

Β 

As targeted in the Company's three-year strategic plan through to May 2028 that was launched in January 2025, the Group's focus on secured lending through its Invoice Finance division and the 'Hard' subset of the wider Asset division has continued. These two product sets now account for approximately 85% of the entire lending book, up from 76% twelve months earlier. They have also accounted for over 95% of all new deals written in the first quarter of this financial year.

Β 

Ed Rimmer, Chief Executive Officer commented:

"As we enter the first year of our new three-year medium-term strategic plan, I am very encouraged that the initial quarter has continued to deliver increased growth in our lending book; a strengthened Balance Sheet with increased Net Tangible Assets; and record quarterly Revenues and Profit Before Tax. The lending book has now seen consistent increases for seventeen consecutive quarters, reflecting the demand for our multi-product offering and the value that is placed on our first-class customer service by UK businesses seeking access to finance. Net arrears and Net Bad Debt write-offs also continue to be well within our target ranges and underline our commitment to responsible and sustainable lending. The Board, therefore, retains confidence that the Group is positioned for further growth and will build increased value for its shareholders over time."

Β 

Outlook

The Board confirms that it continues to expect the Group's trading for the current financial year ending 31 May 2026 to be at least in line with marketΒ expectations.

Β 

Β 

Notice of Investor Presentation

As previously announced, the Company will deliver a live presentation relating to this trading update and the simultaneously released FY 2024/25 audited annual results announcement via the Group's investor website at 1pm BST today. The presentation is open to all existing and potential shareholders who can sign up via: https://investors.timefinance.com/webinars/oPB5mr-fy-results-2024-2025-webinar.

Β 

For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://investors.timefinance.com/s/71ba43. Here you will find all company news and additional content to further explain Time Finance's strategy and developments.

Β 

Ends

Β 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Joe Walker

Timefinance@walbrookpr.com

Β 

Β 

Β 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

Β 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

Β 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTSEMFEDEISEIU
Date   Source Headline
1st Oct 20217:00 amRNSVesting of Share Options
21st Sep 20217:00 amRNS2021 Final Results
7th Sep 20217:00 amRNSNotice of Final Results and Investor Presentation
16th Jun 20217:00 amRNSYear-end Trading Update
10th Jun 20217:00 amRNSPermanent CEO Appointment & Investor Presentation
4th Jun 202111:30 amRNSHolding(s) in Company
4th Jun 202111:25 amRNSHolding(s) in Company
27th May 20215:29 pmRNSEmployee Benefit Trust Share Purchase
27th May 20217:00 amRNSExercise of Options
21st May 20217:00 amRNSUnapproved Share Option Scheme – Vesting of Awards
6th May 20217:00 amRNSNew Loan Accreditation & Financial Calendar Update
22nd Apr 20217:00 amRNSCorporate Update
9th Apr 20212:58 pmRNSEmployee Benefit Trust Share Purchase
26th Mar 20217:00 amRNSDirectorate Change
3rd Mar 20217:00 amRNSFurther re Directorate Change
19th Feb 202112:04 pmRNSDirectorate Changes
3rd Feb 20217:00 amRNSTechnology Infrastructure Update
19th Jan 20217:00 amRNSInterim Results
12th Jan 20217:00 amRNSHolding in Company
12th Jan 20217:00 amRNSHolding in Company
6th Jan 20217:00 amRNSDirectorate Changes
15th Dec 20205:15 pmRNSTR-1: Holding in Company - CORRECTION
9th Dec 20207:00 amRNSHalf Year Trading Update & Investor Presentation
1st Jun 20103:19 pmRNSResult of EGM
28th May 20107:00 amRNSUpdate
6th May 20108:37 amRNSStrategic Review - update
6th May 20107:01 amRNSNotice of EGM
6th May 20107:00 amRNSAppointment of adviser
4th May 201011:22 amRNSForm 8.3 - Timestrip PLC
4th May 20107:00 amRNSForm 8 (OPD) Timestrip
19th Apr 20107:30 amRNSStrategic Review Update and Suspension
19th Apr 20107:30 amRNSSuspension - Timestrip plc
24th Mar 20109:50 amRNSRule 8.1- (Timestrip)
19th Mar 201012:47 pmRNSStrategic Review - Update
18th Mar 20107:00 amRNSStrategic Review
5th Feb 20109:04 amRNSDirectorate Change
3rd Feb 20104:29 pmRNSAIM Rule 17
1st Feb 20107:00 amRNSContract Win - Toothbrush Order
5th Nov 200912:23 pmRNSUK Packaging Awards
28th Oct 20097:00 amRNSTimestrip IV - First full adoption by NHS Trust
26th Oct 20097:00 amRNSTimestrip Medical - 1st order in North America
14th Sep 20097:01 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNHS trials and appointment of distributor
24th Jul 20092:18 pmRNSResult of AGM
6th Jul 20097:00 amRNSNew distribution agreement
1st Jul 20097:00 amRNSPreliminary findings on Timestrip IV
29th Jun 20091:26 pmRNSNotice of AGM
11th Jun 20097:00 amRNSFinal Results
8th May 20097:00 amRNSIssue of Equity
5th May 20097:00 amRNSLuton & Dunstable Hospital orders TimestripIV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.